RYAN SKAPYAK: Open Payments
NPI 1699430058 · SCRANTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$635 in 16 payments from 5 companies in 2025. Trend: 2023 $218 · 2024 $351 · 2025 $635
Food & beverage: $635
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 4 | $254 |
| Madrigal Pharmaceuticals | 5 | $188 |
| Ardelyx, Inc. | 4 | $144 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| Novo Nordisk Inc | 1 | $21 |
Products named: DUPIXENT, REZDIFFRA, IBSRELA, XIFAXAN, Wegovy.
Industry payments across PA — which companies pay providers there.
